- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 12.02. | SunLink Health Systems GAAP EPS of -$0.19, revenue of $7.93M | 1 | Seeking Alpha | ||
| 12.02. | SunLink Health Systems, Inc. Announces Fiscal 2025 Second Quarter Results | 37 | Business Wire | ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $1,070,000 (or a loss of $0.15 per fully diluted share) for its... ► Artikel lesen | |
| 12.02. | SUNLINK HEALTH SYSTEMS INC - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.01. | SUNLINK HEALTH SYSTEMS INC - 8-K, Current Report | 1 | SEC Filings | ||
| 06.01. | SunLink Health Joins Forces With Regional Health Properties In All-Stock Deal: Shares Surge | 1 | Benzinga.com | ||
| 06.01. | Regional Health Properties to acquire SunLink Health in an all-stock deal | 5 | Seeking Alpha | ||
| SUNLINK HEALTH SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 06.01. | Regional Health Properties, Inc.: Regional Health Properties And Sunlink Health Systems To Merge In An All-stock Transaction | 121 | GlobeNewswire (Europe) | Enhances Opportunity to Increase Shareholder Value Significantly Strengthens Balance Sheet Expands Regional Board with the Addition of Two Highly Qualified Industry Veterans Atlanta, GA, Jan. 06,... ► Artikel lesen | |
| 13.11.24 | SunLink Health Systems GAAP EPS of -$0.06, revenue of $7.92M | 1 | Seeking Alpha | ||
| 12.11.24 | SunLink Health Systems, Inc. Announces Fiscal 2025 First Quarter Results | 84 | Business Wire | ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $442,000 (or a loss of $0.06 per fully diluted share) for its first... ► Artikel lesen | |
| 12.11.24 | SUNLINK HEALTH SYSTEMS INC - 10-Q, Quarterly Report | - | SEC Filings | ||
| 25.10.24 | SUNLINK HEALTH SYSTEMS INC - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 11.10.24 | SunLink Health Systems GAAP EPS of $0.61, revenue of $7.91M | 6 | Seeking Alpha | ||
| 10.10.24 | SunLink Health sells hospital building, related real estate of Trace Regional Hospital | 1 | Seeking Alpha | ||
| 01.10.24 | SunLink Health Systems, Inc. Announces Fiscal 2024 Fourth Quarter and Annual Results | 104 | Business Wire | ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $652,000 (or a loss of $0.09 per fully diluted share) for its fourth... ► Artikel lesen | |
| 30.09.24 | SUNLINK HEALTH SYSTEMS INC - 10-K, Annual Report | 1 | SEC Filings | ||
| 15.05.24 | SunLink Health Systems, Inc. Announces Fiscal 2024 Third Quarter Results | 135 | Business Wire | ATLANTA--(BUSINESS WIRE)--SunLink Health Systems, Inc. (NYSE American: SSY) today announced a loss from continuing operations of $824,000 (or a loss of $0.12 per fully diluted share) for its third... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SERNOVA BIOTHERAPEUTICS | 0,128 | -2,59 % | XETR NEW INSTRUMENTS AVAILABLE ON XETRA - 13.02.2025 | Das Instrument PSH0 CA81752F1062 SERNOVA BIOTHERAPEUTICS EQUITY hat seinen ersten Handelstag am 13.02.2025: CONTINUOUS TRADING WITH AUCTIONS, PAG NAM0, SettlCurr EUR, CCP Y
The instrument PSH0 CA81752F1062... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,712 | -2,73 % | ATOSSA THERAPEUTICS, INC. - 8-K, Current Report | ||
| PING AN HEALTHCARE | 1,062 | -1,71 % | Ping An Healthcare and Technology Company Limited: Ping An Health Pioneers AI-Driven Healthcare with DeepSeek Integration | HONG KONG and SHANGHAI, Feb. 13, 2025 /PRNewswire/ -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor", "Ping An Health", or "the Company", Stock Code: 1833.HK) recently... ► Artikel lesen | |
| MOUNTAIN VALLEY MD | 0,014 | -22,58 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,490 | -10,91 % | Co-Diagnostics, Inc. Announces Intention to Submit Enhanced Version of COVID-19 Test to FDA for 510(k) Clearance | The Company is withdrawing current submission based on FDA feedback related to shelf-life stability of a test component
SALT LAKE CITY, Feb. 21, 2025 /PRNewswire/... ► Artikel lesen | |
| CYTOSORBENTS | 1,060 | +2,71 % | CytoSorbents sichert sich 1,6 Millionen US-Dollar durch Optionsscheinausübungen | ||
| VERU | 0,497 | -2,17 % | Veru Inc. Direktor Michael Rankowitz erwirbt Stammaktien im Wert von 84.350 US-Dollar | ||
| TEMPEST THERAPEUTICS | 0,760 | -0,78 % | Tempest Therapeutics: Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma | Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCC Amezalpat builds momentum with both Fast Track and Orphan Drug Designations BRISBANE, Calif.... ► Artikel lesen | |
| VOLITIONRX | 0,575 | 0,00 % | VolitionRx Limited Announces Third Quarter 2024 Financial Results and Business Update | Conference call to discuss financial and operational results scheduled for
Friday, November 15 at 8:30 a.m. U.S. Eastern Time
HENDERSON, Nev., Nov. 14, 2024... ► Artikel lesen | |
| EKSO BIONICS | 0,492 | +1,23 % | Ekso Bionics Holdings Aktie: Droht der Durchbruch zu scheitern? | Die Ekso Bionics Holdings verzeichnete am 22. Februar 2025 einen Kursrückgang von 1,44 Prozent auf 0,5525 USD. Der Hersteller von medizinischen Exoskeletten steht kurz vor der Veröffentlichung seiner... ► Artikel lesen | |
| IMUNON | 0,800 | +1,91 % | Imunon, Inc.: IMUNON Announces New Immunogenicity Data from Phase 1 Clinical Trial of Its DNA Vaccine in Treatment of COVID-19 | Results of IMNN-101 Proof-of-Concept study demonstrate persistent immunogenicity in trial participants and further validate PlaCCine® technology IMNN-101 induced 2- to 4-fold increase in neutralizing... ► Artikel lesen | |
| BEYOND AIR | 0,298 | -3,25 % | Beyond Air COO Michael Gaul erwirbt Stammaktien im Wert von 2.293 US-Dollar | ||
| AVINGER | 0,465 | -22,17 % | Avinger, Inc.: Avinger Reports Third Quarter 2024 Results | Lower Operating Cost Profile Drives Improved Productivity, Increased Gross Margin REDWOOD CITY, CA / ACCESSWIRE / November 7, 2024 / Avinger, Inc. (Nasdaq:AVGR), a commercial-stage medical device company... ► Artikel lesen | |
| NOVACYT | 0,605 | +0,67 % | Novacyt S.A. - IVDR accreditation for Yourgene QST*R Base assay | ||
| AROVELLA THERAPEUTICS | 0,086 | 0,00 % | XFRA E4NA: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen |
Das Unternehmen SUNLINK HEALTH SYSTEMS INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,060 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SUNLINK HEALTH SYSTEMS INC finden Sie auf Wallstreet Online.
